Meritain Eldorado policies, page 106

Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Meritain Eldorado, by title.

Meritain Eldorado policies
PolicyDetailsCodesSource
Specialty Quantity Limit Firdapse 2828-H P20232828-H · Commercial—Original policy ↗
Specialty Quantity Limit Gattex 2245-H P20242245-H · Commercial—Original policy ↗
Specialty Quantity Limit Gavreto 4208-H P20234208-H · Commercial—Original policy ↗
Specialty Quantity Limit Gavreto 4208-H P20254208-H · Commercial—Original policy ↗
Specialty Quantity Limit Humira and Biosimilars 2270-H P2025a2270-H · Commercial—Original policy ↗
Specialty Quantity Limit icatibant-Sajazir-Firazyr 3057-H P20223057-H · Commercial—Original policy ↗
Specialty Quantity Limit Ilumya 2543-H P20252543-H · Commercial—Original policy ↗
Specialty Quantity Limit Inlyta 2214-H P20232214-H · Commercial—Original policy ↗
Specialty Quantity Limit Jakafi 2284-H P2021a2284-H P2021a · Commercial—Original policy ↗
Specialty Quantity Limit Jaypirca 5768-H P2023a5768-H P2023a · Commercial—Original policy ↗
Specialty Quantity Limit Keveyis 2994-H P20232994-H · Commercial—Original policy ↗
Specialty Quantity Limit Kevzara 1953-H P20231953-H · Commercial—Original policy ↗
Specialty Quantity Limit Kisqali 1652-H P20251652-H · Commercial—Original policy ↗
Specialty Quantity Limit Kisqali 1652-H P20251652-H · Commercial—Original policy ↗
Specialty Quantity Limit Koselugo 3772-H P20223772-H · Commercial—Original policy ↗
Specialty Quantity Limit Koselugo 3772-H P20263772-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit lanreotide injection-Somatuline Depot 1710-H P2023a1710-H P2023a · Commercial—Original policy ↗
Specialty Quantity Limit lanreotide injection-Somatuline Depot 1710-H P20241710-H · Commercial—Original policy ↗
Specialty Quantity Limit lenalidomide-Revlimid 2388-H P20232388-H · Commercial—Original policy ↗
Specialty Quantity Limit Lenvima 1698-H P2022a1698-H P2022a · Commercial—Original policy ↗
Specialty Quantity Limit Lenvima 1698-H P20251698-H · Commercial—Original policy ↗
Specialty Quantity Limit Livmarli 5006-H P20265006-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit Livtencity 5073-H P20235073-H · Commercial—Original policy ↗
Specialty Quantity Limit Livtencity 5073-H P20265073-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit Lorbrena 2790-H P20232790-H · Commercial—Original policy ↗
Specialty Quantity Limit Lorbrena 2790-H P20232790-H · Commercial—Original policy ↗
Specialty Quantity Limit Lorbrena 2790-H P20232790-H · Commercial—Original policy ↗
Specialty Quantity Limit Lunsumio 5730-H P2023a5730-H P2023a · Commercial—Original policy ↗
Specialty Quantity Limit Lunsumio 5730-H P2023a5730-H P2023a · Commercial—Original policy ↗
Specialty Quantity Limit Lunsumio 5730-H P2023a5730-H P2023a · Commercial—Original policy ↗
Specialty Quantity Limit Mektovi 2614-H P20232614-H · Commercial—Original policy ↗
Specialty Quantity Limit mifepristone-Korlym 2566-H P20262566-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit Multiple Sclerosis Medications 1798-H P2021b1798-H P2021b · Commercial—Original policy ↗
Specialty Quantity Limit Myalept 2892-H P20262892-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit Neulasta and pegfilgrastim biosimilars 1759-H P2022a1759-H P2022a · Commercial—Original policy ↗
Specialty Quantity Limit Nexavar 2215-H P20222215-H · Commercial—Original policy ↗
Specialty Quantity Limit Nexavar 2215-H P20222215-H · Commercial—Original policy ↗
Specialty Quantity Limit nilotinib products 1724-H P20251724-H · Commercial—Original policy ↗
Specialty Quantity Limit Nucala 2467-H P20262467-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit octreotide products 1709-H P20261709-H P2026 · Commercial—Original policy ↗
Specialty Quantity Limit Onureg 4195-H P20234195-H · Commercial—Original policy ↗
Specialty Quantity Limit Orladeyo 4401-H P2025a4401-H P2025a · Commercial—Original policy ↗
Specialty Quantity Limit Oxervate 3365-H P20223365-H · Commercial—Original policy ↗
Specialty Quantity Limit Oxervate 3365-H P20253365-H · Commercial—Original policy ↗
Specialty Quantity Limit Piqray 3091-H P20263091-H · Commercial—Original policy ↗
Specialty Quantity Limit Pomalyst 2387-H P20222387-H · Commercial—Original policy ↗
Specialty Quantity Limit Rozlytrek 3167-H P20223167-H P2022 · Commercial—Original policy ↗
Specialty Quantity Limit Rydapt 1819-H P20251819-H P2025 · Commercial—Original policy ↗
Specialty Quantity Limit Scenesse 3367-H P20233367-H · Commercial—Original policy ↗
Specialty Quantity Limit Signifor 2567-H P20262567-H P2026 · Commercial—Original policy ↗

Back to Meritain Eldorado

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.